SynthesisPeerJ2025
Fructose consumption and metabolic hypertension in rats: a systematic review and meta-analysis.
Synthesis in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertension is a growing cardiovascular risk, increasingly linked to dietary changes. This meta-analysis examines the impact of dietary fructose on hypertension by evaluating the mean difference in systolic blood pressure (SBP) in rats, considering fructose intake levels (10-30% in solution; 60-75% in diet) and exposure duration (<8 weeks, 8 weeks and >8 weeks). Materials and Methods: A comprehensive search across Cochrane, Web of Science, Scopus and Ovid (MEDLINE, Embase, AMED) databases identified relevant reports published until December 2022. The meta-analysis, conducted using Review Manager 5.4 software, included a total of 24 studies, with quantitative data analysed through a random-effects model. Results: Fructose treatment significantly raised SBP in rats by 31.05 mmHg (95% CI [24.36-37.74], Conclusion: Animal studies suggest that fructose intake may contribute to elevated SBP, potentially increasing the risk of hypertension. While trends were observed across various doses and exposure durations, not all findings reached statistical significance. These observations highlight the importance of further research into the long-term effects of fructose on human blood pressure and their relevance to dietary guidelines and public health policies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.